How Many Deaths Can Be Prevented by Newborn Screening for Congenital Adrenal Hyperplasia?
- 3 January 2007
- journal article
- review article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 67 (6), 284-291
- https://doi.org/10.1159/000098400
Abstract
Congenital adrenal hyperplasia (CAH) is increasingly being included in newborn screening programs. Screening can prevent neonatal mortality in children with salt-wasting CAH, but the number of deaths prevented is not known. Cost-effectiveness analyses of screening require estimates of the probability of mortality in CAH. We reviewed the literature to identify cohort studies of children with CAH ascertained clinically in the absence of screening. We abstracted the numbers of infant deaths attributable to CAH. We also addressed sex ratios among children with clinically detected CAH and the contribution of ascertainment bias to unbalanced ratios. The evidence suggests a probability of infant death due to adrenal crises in salt-wasting CAH of 4% or less in contemporary advanced economies without screening for CAH. This is lower than previous estimates, although the rate of mortality could be considerably higher in populations with limited clinical awareness or access. Although screening for CAH is conducted in a number of countries, further research is still needed to provide reliable estimates on the numbers of prevented deaths, along with evidence-based assessments of the potential benefits, harms, and costs of screening.Keywords
This publication has 46 references indexed in Scilit:
- Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girlsThe Journal of Pediatrics, 2005
- Twenty years experience in rapid identification of congenital adrenal hyperplasia in HungaryEuropean Journal of Pediatrics, 2003
- Lessons From 30 Years of Clinical Diagnosis and Treatment of Congenital Adrenal Hyperplasia in Five Middle European CountriesJournal of Clinical Endocrinology & Metabolism, 2001
- Mortality in patients with congenital adrenal hyperplasia: A cohort studyThe Journal of Pediatrics, 1998
- Newborn screening for congenital adrenal hyperplasia in New ZealandThe Journal of Pediatrics, 1995
- Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency.Archives of Disease in Childhood, 1994
- Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorderScreening, 1993
- Prevalence of congenital adrenal hyperplasia in KuwaitEuropean Journal of Pediatrics, 1990
- Congenital adrenal hyperplasia in Birmingham: a retrospective analysis (1958–1985)Journal of Inherited Metabolic Disease, 1986
- Neonatal screening for congenital adrenal hyperplasia: a programme based on a novel direct radioimmunoassay for 17-hydroxyprogesterone in blood spotsJournal of Endocrinology, 1986